Hoth Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Rocket One

13/11/2024 14:25

* Hoth Therapeutics Inc  HOTH.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -60 cents.  The mean expectation of
three analysts for the quarter was for a loss of 34 cents per
share. Wall Street expected results to range from -37 cents
to -30 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Hoth Therapeutics Inc's reported EPS for the quarter was a
loss
of 31 cents​.
    * The company reported a quarterly loss of $2.13 million.
    * Hoth Therapeutics Inc shares had risen by 2.2% this
quarter and
lost 37.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 20.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Hoth Therapeutics
Inc is $4.00 
This summary was machine generated from LSEG data November 13 at
02:24 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.34          -0.31          Beat
 Jun. 30 2024      -0.43          -0.24          Beat
 Mar. 31 2024      -0.43          -0.46          Missed
 Dec. 31 2023      -0.51          -0.32          Beat